Alex Pearson
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Fibroblast Growth Factor Research 2
- Protein Degradation and Inhibitors 1
- Wnt/β-catenin signaling in development and cancer 1
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Nicholas C. Turner (8 shared papers)Lesley‐Ann Martin (3 shared papers)Rosalind Cutts (2 shared papers)Mitch Dowsett (4 shared papers)Isaac García-Murillas (4 shared papers)Uzma Asghar (2 shared papers)María Teresa Herrera-Abreu (2 shared papers)Marta Guzmán (1 shared paper)
- Journals
- Cancer Research (3 papers)Clinical Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)iScience (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Alex Pearson
14 papers receiving 1.5k citations
Alex Pearson's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 537
- Oncology 918
- Pulmonary and Respiratory Medicine 823
- Genetics 219
- Hematology 83
Countries citing papers authored by Alex Pearson
This map shows the geographic impact of Alex Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Pearson more than expected).
Fields of papers citing papers by Alex Pearson
This network shows the impact of papers produced by Alex Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Pearson. The network helps show where Alex Pearson may publish in the future.
Co-authors
The 25 scholars most cited alongside Alex Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer Hit paper breakdown → | 2016 | 511 |
| 2 | Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer Hit paper breakdown → | 2015 | 416 |
| 3 | 2017 | 203 | |
| 4 | 2019 | 146 | |
| 5 | 2012 | 90 | |
| 6 | 2015 | 37 | |
| 7 | 2007 | 25 | |
| 8 | 2006 | 19 | |
| 9 | 2014 | 8 | |
| 10 | 2017 | 2 | |
| 11 | 2012 | 2 | |
| 12 | 2016 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2015 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Alex Pearson
Alex Pearson is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Cell Biology, having authored 16 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Advanced Breast Cancer Therapies (4 papers), Microtubule and mitosis dynamics (2 papers), Cancer-related Molecular Pathways (2 papers), Fibroblast Growth Factor Research (2 papers), Protein Degradation and Inhibitors (1 paper), Airway Management and Intubation Techniques (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Cancer Research (537 citations), Oncology (918 citations), Pulmonary and Respiratory Medicine (823 citations), Genetics (219 citations) and Hematology (83 citations). Alex Pearson has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Nicholas C. Turner, Lesley‐Ann Martin, Rosalind Cutts, Mitch Dowsett, Isaac García-Murillas, Uzma Asghar, María Teresa Herrera-Abreu, Marta Guzmán, José Baselga and Sunil Pancholi. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, iScience and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.